Over one third of pediatric patients with HS did not meet all three major diagnostic criteria at the time of diagnosis.

Nearly 90% of 1,651 so-called ‘natural’ personal care products contain at least one known allergen, according to a new study from...

Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

Patients with HS who report feelings of stigmatization from their condition had worse QoL and higher levels of depression.

The results of a small study indicate that third-hand smoke (THS)—the incinerated particles of smoke that settle on clothing and other...

Recent findings show that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not...

A recent study has shown that AD and bacterial skin infection rates are higher in Indigenous youth compared to non-Indigenous youth.

According to a new study, models based on cancer registry data can help identify subsets of stage 1 melanoma patients with very low...